Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2014 | 0 | 1.625.000 | 1.625.000 | 1 | ||
2012 | 0 | 2.251.330 | 2.251.330 | 1 | ||
2010 | 0 | 4.398.000 | 1.595.213 | 2 |
Total number of partners: 654
Partner loyalty:
Frequent Partner: (> 2 projects): 146
Rare Partner: 508
Frequent / Rare Partner Ratio: 0.29
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2014-01-01 | Developing Multispecific Biological Agents that Target Tumor Neovasculature for Cancer Imaging and Therapy | BISPROT | participant | 1.625.000 | 1 |
2012-09-01 | Size Matters in Numerical Cognition | SMiNC | participant | 2.251.330 | 1 |
2010-10-01 | Development of an accessible platform for ex vivo site specific post-translational modifications of proteins | ProtLEGO | participant | 1.398.000 | 1 |
2010-10-01 | Crimean Congo Hemorrhagic Fever; Modern Approaches to Diagnostics, Surveillance, Prevention, Therapy and Preparedness | CCH Fever | participant | 3.000.000 | 17 |